Reflow Medical

Reflow Medical has developed a novel retrievable stent system (“Spur”) that achieved FDA De Novo clearance following strong results from the DEEPER REVEAL trial, including a technical success rate of over 99% and low rates of major adverse events at one month. The company’s devices are used to treat complex cardiovascular conditions such as CLTI and peripheral arterial disease by providing temporary mechanical support to blood vessels without leaving permanent metal behind. The company continues to expand its product line with new device iterations and drug-device combinations targeting both peripheral and coronary applications.